SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Qualified Opinion who wrote (2393)6/25/2002 10:50:11 AM
From: arnie h  Read Replies (1) | Respond to of 10345
 
<I read on another board that the .78 per share was his estimated earnings on product sales only.>
That is the case and he specifically used the word 'solid' before the .78.
Indeed, I was surprised by the negative tone of the analysis and the reaction to it as it seemed to me any new 'purchased' earnings have been dead in the water for some time now. It's not clear why commentary about that would have a negative effect at this point.

<I don't expect any substantial findings by the SEC>
Were it not for political aspects, it seems this is the most likely outcome. But there is the need to punish whomever they can. Lord knows how this will turn out?



To: Qualified Opinion who wrote (2393)6/25/2002 11:40:16 AM
From: arnie h  Respond to of 10345
 
<You can probably add at least .30 per share contribution to earnings from investment income.>

Checked back on my notes and he is at $95.5M for the other investment income which works out to be your $.30 figure. He had been at $150M.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News